In addition, CD4+ T cells are also essential to the anti-tumor immune response (Pardoll and Topalian, 1998; Velders et al., 2003), which can directly recognize peptide/class II MHC on the surface of cancer cells and kill them (Echchakir et al., 2000). This evidence concerns the gene HLA-C and cancer.